http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017164298-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-688 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-744 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2017-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2017164298-A1 |
| titleOfInvention | Composition for inhibiting erythema production, method for using the same and method for producing the same, method for inhibiting the production of erythema, lactic acid bacteria product |
| abstract | The subject of this invention is providing the composition for erythema production suppression which can fully suppress the erythema of skin. The composition for suppressing erythema production according to the present invention comprises a lactic acid bacteria product containing a polysaccharide as an active ingredient. The lactic acid bacteria products are at least one of Lactobacillus delbruecki subspecies bulgaricus OLL1247 and Lactobacillus delbrucky subspecies bulgaricus 2038, Streptococcus thermophilus OLS3078, and Streptococcus thermophilus 1131. It is preferable to produce | generate by the combination with at least one of these. Moreover, it is particularly preferable that the composition for suppressing erythema formation further contains at least one of sphingolipid and collagen peptide as an active ingredient. |
| priorityDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 248.